BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND POT1, DKFZP586D211, 25913, ENSG00000128513, hPot1, DKFZp586D211
19 results:

  • 1. A
    Abu Shtaya A; Kedar I; Bazak L; Basel-Salmon L; Barhom SF; Naftali M; Eskin-Schwartz M; Birk OS; Polager-Modan S; Keidar N; Reznick Levi G; Levi Z; Yablonski-Peretz T; Mahamid A; Segol O; Matar R; Bareli Y; Azoulay N; Goldberg Y
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540414
    [TBL] [Abstract] [Full Text] [Related]  

  • 2.
    Jensen MR; Jelsig AM; Gerdes AM; Hölmich LR; Kainu KH; Lorentzen HF; Hansen MH; Bak M; Johansson PA; Hayward NK; Van Overeem Hansen T; Wadt KAW
    HGG Adv; 2023 Oct; 4(4):100225. PubMed ID: 37646013
    [No Abstract]    [Full Text] [Related]  

  • 3. pot1b -/- tumors activate G-quadruplex-induced DNA damage to promote telomere hyper-elongation.
    Takasugi T; Gu P; Liang F; Staco I; Chang S
    Nucleic Acids Res; 2023 Sep; 51(17):9227-9247. PubMed ID: 37560909
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Characterization of pot1 tumor predisposition syndrome: Tumor prevalence in a clinically diverse hereditary cancer cohort.
    Herrera-Mullar J; Fulk K; Brannan T; Yussuf A; Polfus L; Richardson ME; Horton C
    Genet Med; 2023 Nov; 25(11):100937. PubMed ID: 37466057
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma.
    Loh JW; Lee JY; Lim AH; Guan P; Lim BY; Kannan B; Lee ECY; Gu NX; Ko TK; Ng CC; Lim JCT; Yeong J; Lim JQ; Ong CK; Teh BT; Chan JY
    Commun Biol; 2023 Apr; 6(1):461. PubMed ID: 37106027
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup.
    Bruno W; Dalmasso B; Barile M; Andreotti V; Elefanti L; Colombino M; Vanni I; Allavena E; Barbero F; Passoni E; Merelli B; Pellegrini S; Morgese F; Danesi R; Calò V; Bazan V; D'Elia AV; Molica C; Gensini F; Sala E; Uliana V; Soma PF; Genuardi M; Ballestrero A; Spagnolo F; Tanda E; Queirolo P; Mandalà M; Stanganelli I; Palmieri G; Menin C; ; Pastorino L; Ghiorzo P
    ESMO Open; 2022 Aug; 7(4):100525. PubMed ID: 35777164
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to pot1 mutations.
    Martínez P; Sánchez-Vázquez R; Ferrara-Romeo I; Serrano R; Flores JM; Blasco MA
    PLoS Genet; 2022 Jun; 18(6):e1010260. PubMed ID: 35727838
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients.
    Pellegrini C; Raimondi S; Di Nardo L; Ghiorzo P; Menin C; Manganoni MA; Palmieri G; Guida G; Quaglino P; Stanganelli I; Massi D; Pastorino L; Elefanti L; Tosti G; Queirolo P; Leva A; Maurichi A; Rodolfo M; Fargnoli MC;
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):213-221. PubMed ID: 34664323
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Frequent Mutations of pot1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies.
    Shen E; Xiu J; Bentley R; López GY; Walsh KM
    Clin Lung Cancer; 2020 Nov; 21(6):e523-e527. PubMed ID: 32414627
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
    Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
    JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
    [TBL] [Abstract] [Full Text] [Related]  

  • 11.
    Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
    J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. pot1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.
    Calvete O; Garcia-Pavia P; Domínguez F; Mosteiro L; Pérez-Cabornero L; Cantalapiedra D; Zorio E; Ramón Y Cajal T; Crespo-Leiro MG; Teulé Á; Lázaro C; Morente MM; Urioste M; Benitez J
    J Am Heart Assoc; 2019 Sep; 8(18):e012875. PubMed ID: 31510873
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Novel MXD4-NUTM1 fusion transcript identified in primary ovarian undifferentiated small round cell sarcoma.
    Tamura R; Nakaoka H; Yoshihara K; Mori Y; Yachida N; Nishikawa N; Motoyama T; Okuda S; Inoue I; Enomoto T
    Genes Chromosomes Cancer; 2018 Nov; 57(11):557-563. PubMed ID: 30338611
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The wide spectrum of pot1 gene variants correlates with multiple cancer types.
    Calvete O; Garcia-Pavia P; Domínguez F; Bougeard G; Kunze K; Braeuninger A; Teule A; Lasa A; Ramón Y Cajal T; Llort G; Fernández V; Lázaro C; Urioste M; Benitez J
    Eur J Hum Genet; 2017 Nov; 25(11):1278-1281. PubMed ID: 28853721
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A mutation in the pot1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.
    Calvete O; Martinez P; Garcia-Pavia P; Benitez-Buelga C; Paumard-Hernández B; Fernandez V; Dominguez F; Salas C; Romero-Laorden N; Garcia-Donas J; Carrillo J; Perona R; Triviño JC; Andrés R; Cano JM; Rivera B; Alonso-Pulpon L; Setien F; Esteller M; Rodriguez-Perales S; Bougeard G; Frebourg T; Urioste M; Blasco MA; Benítez J
    Nat Commun; 2015 Sep; 6():8383. PubMed ID: 26403419
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Suppression of telomere-binding protein TPP1 resulted in telomere dysfunction and enhanced radiation sensitivity in telomerase-negative osteosarcoma cell line.
    Qiang W; Wu Q; Zhou F; Xie C; Wu C; Zhou Y
    Biochem Biophys Res Commun; 2014 Mar; 445(2):363-8. PubMed ID: 24513288
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.
    Kato M; Nakayama M; Agata M; Yoshida K
    Tumour Biol; 2013 Apr; 34(2):723-33. PubMed ID: 23247865
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparison of genomics and functional imaging from canine sarcomas treated with thermoradiotherapy predicts therapeutic response and identifies combination therapeutics.
    Chi JT; Thrall DE; Jiang C; Snyder S; Fels D; Landon C; McCall L; Lan L; Hauck M; MacFall JR; Viglianti BL; Dewhirst MW
    Clin Cancer Res; 2011 Apr; 17(8):2549-60. PubMed ID: 21292819
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Correlation of telomere length and the expression of its regulating proteins in mesenchymal sarcomas].
    Chi YK; Shen Q; Wang JC; Zheng XZ; Hou L; Zhang B
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):363-8. PubMed ID: 18677381
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.